Neurexis Therapeutics

0 followers


Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.

Industries

Employees

1-10

Links

Org chart

Michael Artinger
CEO & Board Member

Michael Artinger

Collapse
Ulli Bayer
CSO & Board Member
Robyn Goforth
VP, Research & Development